August Global News
Industry news tidbits from around the world.
- Quanticate, a UK-based CRO announced its expansion into the United States via new offices in Cambridge, MA. Earlier this year, the company announced its formation as the merger of two CROs: Statwood and Oxford Pharmaceutical Sciences. It has over 200 employees on three continents.
- Synergy Research Group (Moscow) and Metrics Research (Karachi, Pakistan) have established a CRO alliance. The Metrics' alliance extends Synergy's ability to offer global trial capabilities to sponsors. It already has alliances in Europe, India, the United States, and the Ukraine.
- Lombardia, Italy, is the recipient of a multiyear project to establish a Center of Excellence for Clinical Research. The Lombardia Ministry of Health chose the expertise of the Clinical Research Consortium of Massachusetts (CRCM), which was tapped by the Massachusetts Office of International Trade and Investment (MOITI). Consortium members include BBK Worldwide, Court Square Group, Phase Forward, and Tufts Medical Center's Institute for Clinical Research & Health Policy Studies. CRCM members and MOITI are also pitching the Centers of Excellence for Clinical Research plan to three Latin American countries and two others in Europe.
- European Pharmaceutical Industry Association's (Brussels, Belgium) new Code of Practice went into effect, requiring each company to make publicly available a list of patient organizations to which it provides direct or indirect financial support, or significant nonfinancial support.
Articles in this issue
The Classic Software Debate Takes a Turn
Adventures in Web-Based EDC
Business and People Update August 2008
Outsourcing's Evolution from Commodity to Partner
Balancing the Three-Legged Stool
DIA Adds More History to Boston
Steps to Functional Service Provider Success
Industry Squirms Under Antitrust Spotlight
August Global News
How We Fail to Use CROs Effectively
Recent Videos
Related Content
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Podcast
Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
